Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin + Cetuximab in KRAS Mutant Colorectal Cancer
NCT01190462Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of simvastatin in colorectal cancer (CRC), sponsored by Leiden University Medical Center. Primary endpoint: Percentage of patients free from progression and alive at 12.5 weeks. Status: unknown.
02
Drugs
simvastatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01190462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190462.